medigraphic.com
ISSN 1561-2929 (Print)

2016, Number 1

<< Back Next >>

RCAN 2016; 26 (1)

Morbid processes coexisting with excessive body weight in patients assisted at an institution specialized in neurological disorders

Pérez SMB, Marcos PLM, Sánchez LJ

Language: Spanish
References: 46
Page: 56-70
PDF size: 460.66 Kb.


ABSTRACT

Rationale: Excessive body weight is characterized for the accumulation of energy as fat in amounts higher than those expected from subject´s sex, age and height. Excessive body weight brings about adverse effects upon health, and is associated with an increased presence of chronic morbid events, and an over-expression of vascular risk factors. Objective: To identify morbid processes ocuring in the patient with excessive body weigth assisted at the Clinical Nutrition Ambulatory Office of Institute of Neurology and Neurosurgery of Havana (Cuba). Study design: Descriptive, cross-sectional. Study serie: Eighty-three patients (Males: 38.6%; Ages ≥ 60 years: 22.9%) with exccesive body weight (BMI: 34.7 ± 5.9 Kg.m-2) transfered from the specialized Neurology Office for assessment of vascular risk. Material and method: Presence of Diabetes mellitus (DM), hipertensión arterial (HTA), dislipidemias, and cardio- as well as cerebro-vascular diseases were established by means of an oriented interrogatory; non-alcoholic liver disease (NALD) after ultrasonography; and hyperglucemia (HG), hyperuricemia (HU), hypercholesterolemia (HC), and hipertrigliceridemia (HT) after analytical measurements. Results: Morbid procceses distributed as follows (in descending order): HTA: 54.2%; Cerebrovascular disease: 33.7%; Cardiovascular disease: 13.3%; DM: 18.1%; Dislipidemias: 10.8%; respectively. NALD affected 39.8% of the examined subjects. Frequencies of biochemical disorders were as follows (also in descending order): HC: 37.3%; HT: 36.1%; HG: 26.5%; and HU: 15.6%; respectively. Frequency of Metabolic Syndrome (MS) was 13.3%. Conclusions: HTA is highly prevalent in subjects with exccesive body weight assisted ambulatorily due to cerebrovascular diseases. In addition, these subjects distinguish for NALD and dislipidemias. MS might affect one in every 10 of these subjects.


REFERENCES

  1. Izquierdo Hernández A, Armenteros Borrell M, Lancés Cotilla L, Martín González I. Alimentación saludable. Rev Cubana Enfermería 2004;20:1.

  2. Lobo F. Políticas públicas para la promoción de la alimentación saludable y la prevención de la obesidad. Rev Española Salud Pública 2007;81:437-41.

  3. Martorell R, KettelLHughes ML, Grummer-Strawn LM. Overweight and obesity in preschool children from developing countries. Int J Obes Relat MetabDisord 2000;24(8):959-67.

  4. Organización Mundial de la Salud. Obesidad y sobrepeso. Nota descriptiva número 311 del mes de Marzo del 2011. Disponible en: http://www.who.int/entity/mediacentre/f actsheets/fs311/es/-35k. Fecha de última visita: 13 de Febrero del 2016.

  5. Acosta Jiménez SM, Rodríguez Suárez A, Díaz Sánchez ME. La obesidad en Cuba. Una mirada a su evolución en diferentes grupos poblacionales. RCAN Rev Cubana Aliment Nutr 2013;23: 297-308.

  6. Ochoa C, Muñoz G, Orozco Preciado MA, Mendoza Ceballos ML. La importancia del tratamiento integral del Síndrome metabólico en la prevención de las enfermedades cardiovasculares. RCAN Rev Cubana Aliment Nutr 2012; 22(1 Supl 2):S1-S65.

  7. Morera BP, Rodríguez JF, Fernández Brito JE, Almora C. Pesquisaje de señales ateroscleróticas tempranas en niños de 6 a 11 años de una escuela primaria. Rev Ciencias Médicas Pinar del Río 2013;17:13-25.

  8. Ferrer M, Fernández-Brito JE, Piñeiro R, Carballo R, Sevilla D. Obesidad e hipertensión arterial: Señales ateroscleróticas tempranas en los escolares. Rev Cubana Pediatr 2010; 82:20-30.

  9. Story M. Kaphingst KM, Robinson- O'Brien R, Glanz K. Creating healthy food and eating environments: Policy and environmental approaches. Annu Rev Public Health 2008:29:253-72.

  10. Ballesteros Arribas JM, Dal-Re Saavedra M, Pérez-Farinós N, Villar Villalba C. La estrategia para la nutrición, actividad física y prevención de la obesidad: Estrategia NAOS. Rev Española Salud Pública 2007;81:443-9

  11. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V; et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010.The Lancet 2013;380:2095-2128.

  12. Anónimo. Anuario Estadístico de la Salud. 2015. MINSAP Ministerio de Salud Pública. La Habana: 2016. Disponible en: http://bvscuba.sld.cu/anuario-estadisticode- cuba/. Fecha de última visita: 10 de Febrero del 2016.

  13. Pérez Álvarez CA. Caracterización del accidente transitorio isquémico en pacientes con infarto cerebral. Tesis de terminación de residencia en Neurología. Universidad de Ciencias Médicas de La Habana. Ciudad Habana: 2010.

  14. Grupo de Apoyo Nutricional. PNO 2.016.98. Encuestas dietéticas. Manual de Procedimientos. Hospital Clínico quirúrgico “Hermanos Ameijeiras”. Segunda Edición. La Habana: 2012.

  15. Hernández M, Porrata C, Jiménez S, Rodríguez A, Carrillo O, García A. Recomendaciones nutricionales de la población cubana. Cámara del Libro de Cuba. La Habana: 2009.

  16. Weiner JS, Lourie JA. Human biology. A guide to field methods. International Biological Program. Handbook number 9. Blackwell Scientific Publications. Oxford: 1969.

  17. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Second Edition. Human Kinetics Books. Champaign [Illinois]: 1991. Pp 44-47.

  18. WHO Working Group. Use and interpretation of anthropometric indicators of nutritional status. Bulletin WHO 1986;64:929-41.

  19. Seidel JC, Deurenberg P. Fat distribution of overweight persons in relation to morbidity and subjective health. Int J Obesity 1985;9:363-74.

  20. Anónimo. Tablas de referencias y valores normales de las pruebas de laboratorio más habituales. Disponible en: http://www.sld.cu/galerias/pdf/sitios/hem atologia/valores_de_laboratorio.pdf. Fecha de última visita: 3 de Marzo del 2016.

  21. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Disponible en: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf. Fecha de última visita: 11 de Diciembre del 2015.

  22. Naciones Unidas. Declaración Universal sobre Bioética y Derechos Humanos. 33 Sesión de la Conferencia General de la UNESCO. Ginebra: 2005. Disponible en: http://www.unesco.org/shs/ethics. Fecha de última visita: 13 de Enero del 2016.

  23. Naciones Unidas. Report of the International Bioethics Committee of UNESCO on the principle of respect for human vulnerability and personal integrity.2013. Disponible en: http://www.unesco.org/shs/bioethics. Fecha de última visita: 13 de Enero del 2016.

  24. Mackay J, Mensah G. The Atlas of Heart Disease and Stroke. World Health Organization. Geneva [Switzerland]: 2004. Disponible en: http://www.who.int/cardiovasculardiseas es/resources/atlas/en. Fecha de última visita: 14 de Enero del 2016.

  25. Ghatnekar O, Persson U, Glader EL, Terént A. Cost of stroke in Sweden: An incidence estimate. Int J Technol Assess Health Care 2004;20:375-80.

  26. Hankey GJ, Warlow C. Treatment and second prevention of stroke: Evidence, costs and effects on individuals and populations. Lancet 1999;354:1457-63.

  27. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C; et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet 2014;384(9945):766-81.

  28. Jiménez S, Díaz ME, Barroso I, Bonet M, Cabrera A, Wong I. Estado nutricional de la población cubana adulta. Rev Esp Nutr Com [España] 2005;11:18-26.

  29. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: Tracking obesity to its source. Cell 2007;131: 242-256.

  30. Pottie P, Presle N, Terlain B, Netter P, Mainard D, Berenbaum F. Obesity and osteoarthritis: More complex than predicted! Ann Rheumatic Dis 2006;65: 1403-05.

  31. Flamme CH. Obesity and low back pain- Biology, biomechanics and epidemiology. Der Orthopade 2005;34:652-7.

  32. Cordido F, Garcia-Mayor RV, Larranaga A. Obesity, adipose tissue, inflammation and update on obesity management. Obes Control Ther 2014;1:1-8.

  33. Winter Y, Rohrmann S, Linseisen J, Lanczik O, Ringleb PA, Hebebrand J, Back T. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke 2008; 39:3145-51.

  34. Kurth T, Gaziano JM, Rexrode KM, Kase CS, Cook NR, Manson JE, Buring JE. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 2005;111: 1992-8.

  35. Song YM, Sung J, Davey Smith G, Ebrahim S. Body mass index and ischemic and hemorrhagic stroke: A prospective study in Korean men. Stroke 2004;35:831-6.

  36. Phelan S, Wadden TA, Berkowitz RI, Sarwer DB, Womble LG, Cato RK, Rothman R. Impact of weight loss on the metabolic syndrome. Int J Obes 2007; 31:1442-8.

  37. Santana Porbén S. Las adipocitoquinas en la génesis y evolución del Síndrome metabólico. RCAN Rev Cubana Aliment Nutr 2010;20(2):304-17.

  38. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A; et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-8.

  39. Isozumi K. Obesity as a risk factor for cerebrovascular disease. The Keio J Med 2004;53:7-11.

  40. Parikh RM, Mohan V. Changing definitions of metabolic syndrome. Indian J Endocrinol Metab 2012;16:7-12.

  41. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; for the Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360 (9349):1903-13.

  42. Koren-Morgag N, Tanne D, Graff E, Goldbourt U. Low-and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: The Bezafibrate Infarction Prevention Registry. Arch Intern Med 2002;162:993-9.

  43. Pérez S, Díaz Perera G. Circunferencia de la cintura en adultos, indicador de riesgo de aterosclerosis. Rev Haban Cienc Med [La Habana: Cuba] 2011;10:441-7.

  44. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative metaanalysis of 102 prospective studies. The Lancet 2010;375(9733):2215-22.

  45. Sturm R, Wells KB. Does obesity contribute as much to morbidity as poverty or smoking? Public Health 2001; 115:229-35.

  46. Suárez Lugo N. El consumo de productos manufacturados del tabaco en Cuba. Rev Cubana Salud Pública 2006; 32(2):0-0. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_ arttext&pid=S0864- 34662006000200002. Fecha de última visita: 23 de Febrero del 2016.




2020     |     www.medigraphic.com